FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Clinical cancer research, 2019-07, Vol.25 (13), p.3753-3758 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-4070 ;PMID: 30787022
Full text available